Cancer treatments have advanced significantly in recent decades, but the search continues for therapies that are more effective and less toxic for patients. A class of drugs called PARP inhibitors has emerged as a promising new option, particularly for certain types of breast, ovarian, and other cancers. These inhibitors target DNA repair pathways in cancer cells, helping chemotherapy and...
0 Commentarios
0 Acciones
1419 Views
0 Vista previa
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian